Clinical Trial Update: AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas [Phase 2]

View source ↗

Summary

A Phase 2 adaptive biomarker-driven trial focusing on organ preservation for gastroesophageal adenocarcinoma; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Adenocarcinoma

Snippet

Sponsor: American Association for Cancer Research | Conditions: Gastroesophageal Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING